Latest News
Rubrik Stock Dips 7% Ahead of Q2 Report Despite Wells Fargo's Raised Target
Rubrik shares slid 7% to $91 on Tuesday, even as Wells Fargo boosted its price target to $120. The market braces for Q2 earnings due Thursday.
707 Cayman Stock Soars 58% on $10.25M Deal Financing
707 Cayman shares surged 57.85% to $6.03 after a $10.25M financing plan for the acquisition of Crucial Innovation, despite the deal being non-binding and target financials undisclosed.
CoreWeave Gains 2.3% as Rescale Adds AI Cloud for Five Industries
CoreWeave (CRWV) shares climbed 2.3% as Rescale launched AI cloud services for five industries, broadening its workload mix beyond AI training.
ParaZero Soars 29% on First US Federal DefendAir Order
ParaZero shares surged 29% after a US federal agency placed its first DefendAir order, though the undisclosed value leaves revenue impact unclear.
Marvell Stock Surges 5% as Analysts Lift Targets Ahead of Q2 Report
Marvell shares climbed 5% after analysts raised price targets, with options pricing a 10.6% earnings swing ahead of Thursday's report.
Strive Stock Surges 9% on Bitcoin Buy, But Per-Share Gains Limited
Strive (ASST) shares jumped 9% after its latest Bitcoin purchase, but per-share gains were limited by dilution and preferred share claims.
RUM Group Surges 12% on $13.7B GPU Deal, But Dilution Risks Loom
RUM Group shares climbed 12% on a $13.7B GPU deal, but a 50.8M-share warrant and unfunded project raise dilution and financing risks.
Navitas Surges 5% on $233M Claros Buyout to Power AI Chips
Navitas Semiconductor (NVTS) rose 5.3% after announcing the $232.8M acquisition of Claros, a move to enhance AI chip power delivery. The deal expands Navitas's market opportunity by $3.5B but introduces dilution and execution risks.
CRISPR Therapeutics Stock Jumps Ahead of Key CTX310 Data
CRISPR Therapeutics shares climbed 5.8% to $60.38 ahead of CTX310 results due Aug 28. Analysts maintain an $80 target, citing potential as a one-time therapy.
AMD Soars 4% on Strong Buy Upgrade; Server CPU Market Seen at $201B
AMD shares rose 4.3% after Raymond James upgraded to Strong Buy, lifting its price target to $641. The firm forecasts the server CPU market to reach $201B by 2030.
Generate Biomedicines Surges 12% Ahead of Lockup Expiry
Generate Biomedicines (GENB) shares jumped 12.3% ahead of the expiration of a 103.14 million-share lockup, with trading volume nearly four times the average.
Richtech Robotics Stock Soars 17% on $12M Buyback Amid Heavy Dilution
Richtech Robotics shares surged 17% on a $12M buyback authorization, but the program covers only a fraction of recent dilution as share count has doubled in a year.